Nicotine Inhibits Clostridium difficile Toxin A-Induced Colitis but Not Ileitis in Rats

International Journal of Inflammation
S R Vigna

Abstract

Nicotine is protective in ulcerative colitis but not Crohn's disease of the small intestine, but little is known about the effects of nicotine on Clostridium difficile toxin A-induced enteritis. Isolated ileal or colonic segments in anesthetized rats were pretreated with nicotine bitartrate or other pharmacological agents before intraluminal injection of toxin A. After 3 hours, the treated segments were removed and inflammation was assessed. Nicotine biphasically inhibited toxin A colitis but not ileitis. Pretreatment with the nicotinic receptor antagonist, hexamethonium, blocked the effects of nicotine. Pretreating the colonic segments with hexamethonium before toxin A administration resulted in more inflammation than seen with toxin A alone, suggesting that a tonic nicotinic anti-inflammatory condition exists in the colon. Nicotine also inhibited toxin A-induced increased colonic concentrations of the TRPV1 (transient receptor potential vanilloid subtype 1) agonist, leukotriene B4 (LTB4), and release of the proinflammatory neuropeptide, substance P. Pretreatment with nicotine did not protect against direct TRPV1-mediated colitis caused by intraluminal capsaicin. Nicotinic cholinergic receptors tonically protect the colon agai...Continue Reading

References

Mar 1, 1982·The Journal of Investigative Dermatology·P P BradleyG Rothstein
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·C PothoulakisS E Leeman
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·P W MantyhJ E Maggio
May 4, 1995·European Journal of Pharmacology·J P Van DijkF J Zijlstra
Mar 24, 1994·The New England Journal of Medicine·R D PullanG A Thomas
Nov 1, 1996·European Journal of Gastroenterology & Hepatology·C Pothoulakis
May 21, 1999·Neuroscience·P T MannJ B Furness
Sep 29, 1999·Gastroenterology·F GaleazziS M Collins
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·S W HwangU Oh
Aug 25, 2000·European Journal of Gastroenterology & Hepatology·D T Rubin, S B Hanauer
Aug 26, 2000·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·A P SykesM E Parsons
Feb 24, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·C Pothoulakis, J T Lamont
Feb 24, 2001·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·J K KoC H Cho
Jun 20, 2002·European Journal of Gastroenterology & Hepatology·Rami EliakimMark W Babyatsky
Jan 23, 2003·The Journal of Pharmacology and Experimental Therapeutics·Douglas C McVeySteven R Vigna
May 26, 2004·Best Practice & Research. Clinical Gastroenterology·Jacques Cosnes
May 12, 2005·Gastroenterology·Douglas C McVey, Steven R Vigna
Oct 12, 2005·The Journal of Experimental Medicine·Misha D LuyerWim A Buurman
May 1, 2007·World Journal of Gastroenterology : WJG·A Karban, R Eliakim
Jan 13, 2010·Environmental Health Perspectives·Amy R SapkotaTimothy M Vogel
Apr 29, 2010·British Journal of Pharmacology·Susanne A SnoekWouter J de Jonge
Jun 6, 2012·The Journal of Experimental Medicine·Ulf Andersson, Kevin J Tracey
Aug 1, 2012·PloS One·Mary A M RogersDavid M Aronoff

❮ Previous
Next ❯

Methods Mentioned

BETA
glucosylation

Software Mentioned

Adobe Photoshop
GraphPad Prism

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here